drugset / Trial / NCT07244289
Managed Access Programs for VAY736, Ianalumab
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to VAY736, ianalumab
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Ianalumab | Monoclonal antibody | — | — |